EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor

Hao Xiong iD, Zhu Shen

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Hao Xiong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Chi…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunotherapy, Neoplasms, Memory T Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: Guangzhou Municipal Commission of Science and Technology Program, Basic and Applied Basic Research Foundation Program of Guangdong Province, Supporting Fund for Young Scientist to National Natural Science of China Application.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue‐resident memory T cells (TRM) are a specialized subset of T cells that reside in tissues and provide long‐term protective immunity against pathogens that enter the body through that specific tissue. TRM cells have specific phenotype and reside preferentially in barrier tissues. Recent studies have revealed that TRM cells are the main target of immune checkpoint inhibitor immunotherapy since their role in cancer immunosurveillance. Furthermore, TRM cells also play a crucial part in pathogenesis of immune‐related adverse events (irAEs). Here, we provide a concise review of biological characteristics of TRM cells, and the major advances and recent findings regarding their involvement in immune checkpoint inhibitor immunotherapy and the corresponding irAEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsImmunotherapyNeoplasmsMemory T CellsHumansImmunologic MemoryAnimals

Stichwörter der Autor:innen

immune checkpoint inhibitor (ICIs)immune‐related adverse events (irAEs)immunotherapytissue‐resident memory T cells (TRM)

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.

ORCID-Profile: Hao Xiong

Förderung

  • Guangzhou Municipal Commission of Science and Technology Program
  • Basic and Applied Basic Research Foundation Program of Guangdong Province
  • Supporting Fund for Young Scientist to National Natural Science of China Application
  • National Natural Science Foundation of China

Zitieren

APA

Xiong, H., & Shen, Z. (2024). Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor. International Journal of Cancer. https://doi.org/10.1002/ijc.34940

Vancouver

Xiong H, Shen Z. Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor. International Journal of Cancer. 2024. doi:10.1002/ijc.34940

BibTeX
@article{Xiong2024,
  author = {Xiong, Hao and Shen, Zhu},
  title = {Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34940}
}
Kostenlos starten →